Amgen cuts cholesterol drug price by 60 percent
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Annual report shows tax reform hit Amgen hard
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s chief financial officer to depart
Chief Financial Officer Jonathan M. Peacock is leaving Amgen to pursue broader career opportunities, the company announced. Michael A. Kelly has been named acting CFO.
Amgen Q2 earnings up 8 percent
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-01-2012″ enddate=”26-07-2012″ width=”300″ height=”245″] Amgen’s earnings beat market expectations in the second quarter and rose 8.2 percent, the Thousand Oaks-based biotech giant said in a July 26 report. The company reported a profit of $1.27 billion, or $1.61 a share, up from $1.17 billion, or $1.25 a share, a year Read More →
